Renal papillary necrosis
For patient information page,click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Synonyms and keywords:: Papillary necrosis, RPN
Overview
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Overview
Renal papillary necrosis is a form of nephropathy involving the ischemic necrosis of the renal papilla, which is supplied by the vasa recta. Renal papillary necrosis is a significant kidney disorder, which is associated with chronic conditions such as diabetes, sickle cell disease, urinary tract obstruction, urinary tract infection and long term use of analgesics containing phenacetin.
Historical Perspective
Renal papillary necrosis was first introduced by Friedrich in 1877, following urinary obstruction. Then, other associated factors such as diabetes, sickle cell disease and analgesics have been found.
Pathophysiology
It is thought that Renal papillary necrosis is the result of damage to interstitial medullary and papillary cells due to direct effect of diseases such as diabetes, sickle cell disease, urinary tract obstruction, renal vein thrombosis, upper urinary tract infection, tuberculosis, vasculitis, renal transplant rejection and long term analgesics use such as acetaminophen and NSAIDs. Decreased prostaglandin synthesis and subsequent reduced renal blood flow is an important mechanism for developing renal papillary necrosis. Accumulation of sickle-shaped RBCs in patients with sickle cell disease can lead to intravascular obstruction, blood stasis and thrombosis that results in ischemic necrosis of renal papillary and medullary cells.
Causes
Renal papillary necrosis is associated with damaging the renal medullary and papillary cells due to many diseases such as diabetes, sickle cell disease, urinary tract obstruction, renal vein thrombosis, pyelonephritis, tuberculosis, vasculitis, cirrhosis, renal transplant rejection and long term analgesics and alcohol abuse. In infants, it is associated with asphyxia, dehydration, and sepsis.
Classification
Renal papillary necrosis may be classified according to the severity of renal parenchymal lesions into two subtypes: Medullary and Papillary.
Differential Diagnosis
Renal papillary necrosis should be differentiated from other conditions presenting with acute flank or upper abdominal pain, hematuria, nausea and vomiting. The differentials include: nephrolithiasis, pyelonephritis, renal infarct, renal cell carcinoma, pelvic inflammatory disease, ovarian torsion, testicular torsion, prostatitis, prostatic cancer, ectopic pregnancy, orchitis, appendicitis, cholecystitis, ischemic colitis, peptic ulcer disease, portal vein thrombosis, diverticulitis, abdominal aortic aneurysm.
Epidemiology and Demographics
The prevalence and demographic characteristics of renal papillary necrosis depend on the causative agent.*Renal papillary necrosis due to analgesic abuse is more prevalent in Australia and England and less in the US. The prevalence of renal papillary necrosis was reported 65,000 per 100,000 patients with sickle cell disease.In developing countries, the incidence of renal papillary necrosis is 3900 per 100,000 persons.The prevalence of renal papillary necrosis increases with age. It commonly affects the elderly (>60 years).Renal papillary necrosis due to sickle cell disease commonly affects adults in the third and fourth decades.Renal papillary necrosis is more prevalent in women.
Risk Factors
Natural History, Complications & Prognosis
Common complications of renal papillary necrosis include Kidney infection and stones, chronic renal failure, kidney cancers, hypertension, anemia and ESRD. Prognosis depends on the underlying condition.
Diagnosis
The diagnosis of renal papillary necrosis is made by a history of having high-risk conditions such as analgesic abuse and urinalysis and Ultrasound, CT, or other imaging tests of the kidneys.
History and Symptoms
The most common symptoms of renal papillary necrosis include back pain, fever, bloody urine, presence of tissues in urine, Cloudy urine, dysuria, frequency, urgency and urinary incontinency. History of medical conditions such as diabetes and sickle cell disease and long term analgesics use such as acetaminophen and NSAIDS should be considered. If left untreated or progressed, symptoms of chronic renal failure may be developed.
Physical Examination
Common physical examination findings of renal papillary necrosis include fever, costovertebral angle tenderness, and hematuria.
Laboratory Findings
X-ray
CT Scan
CT urography is helpful in the diagnosis of renal papillary necrosis that shows multiple small accumulations of contrast media in the papillary regions near the calyx system. The lobster claw sign is a diagnostic finding on CT urography in the papillary subtype of renal papillary necrosis that develops due to elongation of the minor calyx fornices following ischemia and destruction of the renal papilla.
MRI
MRI can be used as a helpful alternative imaging test in children suspected renal papillary necrosis. On Magnetic resonance urography, renal papillary necrosis is characterized by classic signs of papillary necrosis including candle-flame appearance, Golf ball on a tee sign, lobster claw sign and clubbing of calyces.
Other Imaging Findings
Biopsy
On renal biopsy, renal papillary necrosis is characterized by necrosis of papilla, swelling and sloughing of papilla, mild inflammation and microcalcification at necrotic area.
Treatment
The mainstay of therapy in renal papillary necrosis is supportive care and treating the underlying cause such as discontinuation of analgesics. In severe cases, dialysis or renal replacement therapy may be required.
Medical Therapy
The mainstay of therapy is supportive care and treating the underlying cause.
Surgery
In severe cases of renal papillary necrosis leading to chronic kidney disease, dialysis or renal replacement therapy may be required.
Prevention
Effective measures for the primary prevention of renal papillary necrosis include controlling underlying diseases such as diabetes or sickle cell anemia, avoid taking over-the-counter analgesics and using the minimum dose of NSAIDs within the shortest time.
References
Historical Perspective
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Overview
Renal papillary necrosis was first introduced by Friedrich in 1877, following urinary obstruction. Then, other associated factors such as diabetes, sickle cell disease and analgesics were found.
Discovery
- Renal papillary necrosis was first discovered by professor Friedrich in 1877, in a patient following urinary obstruction due to prostatic hyperplasia. [1]
- Gunther and Edmonson found association between RPN and diabetes mellitus. [2]
- Analgesic nephropathy was first described by Spuhler and Zollinger in 1953 due to chronic use of pain killer medications containing phenacetin. [3]
- The association between RPN and sickle cell disease was found by Sydenstricker in 1923. [2]
Landmark Events in the Development of Treatment Strategies
Impact on Cultural History
Famous Cases
References
- ↑ Friedreich, N. (1877). “Ueber Necrose der Nierenpapillen bei Hydronephrose”. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 69 (2): 308–312. doi:10.1007/BF02326121. ISSN 0945-6317.
- ↑ 2.0 2.1 Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K (2016). “Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria”. Niger J Clin Pract. 19 (4): 471–4. doi:10.4103/1119-3077.183299. PMID 27251962.
- ↑ SPUHLER O, ZOLLINGER HU (1953). “[Chronic interstitial nephritis]”. Z Klin Med. 151 (1): 1–50. PMID 13137299.
Classification
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Overview
Renal papillary necrosis may be classified according to the severity of renal parenchymal lesions into two subtypes: Medullary and Papillary.
Classification
- Renal papillary necrosis may be classified according to the severity of renal parenchymal lesions into two subtypes[1]:
Staging of Renal papillary necrosis
- According to the histological finding of renal papillary necrosis, there are five grades based on the severity. “Renal Papillary Necrosis – an overview | ScienceDirect Topics”.
- Grade 1
- involvement of microvasculature, loop of Henle, and interstitial cells, which replaced by eosinophilic material
- intact collecting ducts
- Grade 2
- Grade 3
- Grade 4
- Grade 5
- necrosis that extends to the extra-medullary area
- Grade 1
References
- ↑ Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K (2016). “Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria”. Niger J Clin Pract. 19 (4): 471–4. doi:10.4103/1119-3077.183299. PMID 27251962.
Pathophysiology
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Overview
Renal papillary necrosis is a significant kidney disorder, which is associated with ischemia of the inner renal medulla and papilla due to chronic conditions such as diabetes, sickle cell disease, urinary tract obstruction, urinary tract infection and long term use of analgesics. Decreased prostaglandin synthesis and subsequent reduced renal blood flow is an important mechanism for developing renal papillary necrosis.
Pathogenesis
- The exact pathogenesis of renal papillary necrosis is not fully understood.
- It is thought that Renal papillary necrosis is the result of damage to interstitial medullary and papillary cells due to direct effect of diseases such as diabetes, sickle cell disease, urinary tract obstruction, renal vein thrombosis, upper urinary tract infection, tuberculosis, vasculitis, renal transplant rejection and long term analgesics use such as acetaminophen and NSAIDS. [1][2][3]

- Renal medullary and papillary cells are susceptible to ischemia. [5]
- Medullary cells usually produce prostaglandins and proteoglycans. [1]
- Damage of medullary cells leads to changes in renal matrix and vessels due to decreased production of prostaglandins that causes vasoconstriction, reduced renal perfusion, ischemia and necrosis. [1][6]
- Another mechanism is inhibiting cyclooxygenase enzymes; COX I and COX II, which play a major role in the prostaglandins synthesis, following NSAIDS use. [7]
- Multiple NSAIDS taking and hypovolemic condition could facilitate development of renal papillary necrosis. [1] [2]
- Accumulation of sickle-shaped RBCs in patients with sickle cell disease can lead to intravascular obstruction, blood stasis and thrombosis that results in ischemic necrosis of renal papillary and medullary cells.[8]
Gross Pathology
- The most important characteristics of renal papillary necrosis on gross pathology are irregular round shaped necrosis of renal papillary and medullary area. [9] [3]
Microscopic Pathology
- On microscopic histopathological analysis, the characteristic findings of renal papillary necrosis include[9][10][11]:
- Coagulative necrosis of papillary area
- swelling and sloughing of papilla
- partial necrosis of medullary area
- mild inflammation at necrotic area
- microcalcifications at necrotic area
- Other renal histological findings include[9][12]:
- diabetic nephropathy:
- analgesic nephropathy:
- interstitial fibrosis
- cytoplasmic edema
- dilation of organelles
- increased production of proteoglycan
- tubular atrophy
- endothelial cell injury
- damage to loops of Henle
- Platelet thrombus
- sickle cell nephropathy:
References
- ↑ 1.0 1.1 1.2 1.3 Brix AE (2002). “Renal papillary necrosis”. Toxicol Pathol. 30 (6): 672–4. doi:10.1080/01926230290166760. PMID 12512867.
- ↑ 2.0 2.1 Sabatini S (1984). “Pathophysiology of drug-induced papillary necrosis”. Fundam Appl Toxicol. 4 (6): 909–21. doi:10.1016/0272-0590(84)90229-x. PMID 6394414.
- ↑ 3.0 3.1 Geller SA, de Campos FPF (2013). “Renal papillary necrosis”. Autops Case Rep. 3 (4): 69–71. doi:10.4322/acr.2013.042. PMC 5453664. PMID 28584810.
- ↑ By BruceBlaus. When using this image in external sources it can be cited as:Blausen.com staff (2014). “Medical gallery of Blausen Medical 2014”. WikiJournal of Medicine 1 (2). DOI:10.15347/wjm/2014.010. ISSN 2002-4436. – Own work, CC BY 3.0, https://commons.wikimedia.org/w/index.php?curid=31118599
- ↑ Jung DC, Kim SH, Jung SI, Hwang SI, Kim SH (2006). “Renal papillary necrosis: review and comparison of findings at multi-detector row CT and intravenous urography”. Radiographics. 26 (6): 1827–36. doi:10.1148/rg.266065039. PMID 17102053.
- ↑ Burrell JH, Yong JL, Macdonald GJ (1990). “Experimental analgesic nephropathy: changes in renal structure and urinary concentrating ability in Fischer 344 rats given continuous low doses of aspirin and paracetamol”. Pathology. 22 (1): 33–44. doi:10.3109/00313029009061423. PMID 2362779.
- ↑ Brater DC, Harris C, Redfern JS, Gertz BJ (2001). “Renal effects of COX-2-selective inhibitors”. Am J Nephrol. 21 (1): 1–15. doi:10.1159/000046212. PMID 11275626.
- ↑ Henderickx MMEL, Brits T, De Baets K, Seghers M, Maes P, Trouet D; et al. (2017). “Renal papillary necrosis in patients with sickle cell disease: How to recognize this ‘forgotten’ diagnosis”. J Pediatr Urol. 13 (3): 250–256. doi:10.1016/j.jpurol.2017.01.020. PMID 28341428.
- ↑ 9.0 9.1 9.2 “Renal Papillary Necrosis – American Urological Association”.
- ↑ “Renal papillary necrosis | Radiology Reference Article | Radiopaedia.org”.
- ↑ Lindvall N (1978). “Radiological changes of renal papillary necrosis”. Kidney Int. 13 (1): 93–106. doi:10.1038/ki.1978.12. PMID 713272.
- ↑ Gregg NJ, Courtauld EA, Bach PH (1990). “High resolution light microscopic morphological and microvascular changes in an acutely induced renal papillary necrosis”. Toxicol Pathol. 18 (1 Pt 1): 47–55. doi:10.1177/019262339001800107. PMID 2194275.
Causes
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Overview
- Renal papillary necrosis is associated with damaging the renal medullary and papillary cells due to many diseases such as diabetes, sickle cell disease, urinary tract obstruction, renal vein thrombosis, pyelonephritis, tuberculosis, vasculitis, cirrhosis, renal transplant rejection and long term analgesics and alcohol abuse. In infants, it is associated with asphyxia, dehydration, and sepsis.
Causes
- Common causes of renal papillary necrosis include[1][2][3]:
- Diabetes
- Sickle cell disease: most common cause in children
- Urinary tract obstruction
- Renal vein thrombosis
- upper urinary tract infection or pyelonephritis
- Tuberculosis
- liver cirrhosis
- systemic vasculitis
- Renal transplant rejection
- chronic alcohol abuse
- abuse of acetaminophen and analgesics containing phenacetin such as NSAIDs
- Renal papillary necrosis may also occur less commonly in infants due to[4]:
- There is a mnemonic for the causes of renal papillary necrosis[5] : POSTCARDS:
- Pyelonephritis
- Obstruction of the urogenital tract
- Sickle cell disease
- Tuberculosis
- Cirrhosis
- Analgesia/Alcohol abuse
- Renal vein thrombosis
- Diabetes mellitus
- Systemic vasculitis
References
- ↑ Brix AE (2002). “Renal papillary necrosis”. Toxicol Pathol. 30 (6): 672–4. doi:10.1080/01926230290166760. PMID 12512867.
- ↑ Sabatini S (1984). “Pathophysiology of drug-induced papillary necrosis”. Fundam Appl Toxicol. 4 (6): 909–21. doi:10.1016/0272-0590(84)90229-x. PMID 6394414.
- ↑ Henderickx MMEL, Brits T, De Baets K, Seghers M, Maes P, Trouet D; et al. (2017). “Renal papillary necrosis in patients with sickle cell disease: How to recognize this ‘forgotten’ diagnosis”. J Pediatr Urol. 13 (3): 250–256. doi:10.1016/j.jpurol.2017.01.020. PMID 28341428.
- ↑ Husband P, Howlett KA (1973). “Renal papillary necrosis in infancy”. Arch Dis Child. 48 (2): 116–20. doi:10.1136/adc.48.2.116. PMC 1648192. PMID 4690507.
- ↑ Kim, Seung Hyup (2011-11-19). Radiology Illustrated: Uroradiology. Springer Science & Business Media. p. 471. ISBN 9783642053221.
[[Category:Disease]
Differentiating Renal papillary necrosis from other Diseases
Overview
Differentiating Renal Papillary Necrosis From Other Diseases
Renal papillary necrosis should be differentiated from other conditions presenting with acute flank or upper abdominal pain, hematuria, nausea and vomiting. The differentials include the following:[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34]
| Category | Disease | History | Signs and Symptoms | Physical Examination | Laboratory abnormalities | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nausea/vomiting | Hematuria | Location of pain | Fever | Tachycardia | Hypotension | Hypertension | Anorexia | Constipation | Rebound abdominal tenderness | Urinary frequency/Urgency/Dysuria | Costovetebral angle tenderness | Pelvic Examination | Rectal Examination | Complete Blood Count (CBC) | Urinalysis | BUN | Creatinine | Stone analysis | Urine Beta- hCG | Abnormal Liver Function Tests (LFTs) | Serum Amylase/Lipase | Abdominal/Pelvic CT scan | Serum Parathyroid hormone levels (PTH) | |||
Renal Pathology |
Nephrolithiasis |
|
+ | + | – | + | – | – | +/- | – | – | + | – | – | – | – | – | – | – |
|
+/- | |||||
| Pyelonephritis |
|
+ | + (microscopic) |
|
+ | + | + | – | +/- | – | + | + | + | – |
|
– | – | – | – |
|
– | |||||
| Renal infarct | + | + | + | + | – | + | – | – | – | – | – | – | – | – | – | – | ||||||||||
| Renal papillary necrosis | – | + (microscopic) | + | +/- | – | + | – | – | – | + | – | – | – | – | – | – | – |
|
– | |||||||
| Renal cell carcinoma |
|
+ | + (microscopic) | – | – | – | + | + | +/- | – | – | – | – | – |
|
|
– | – | – | – |
|
– | ||||
| Uretral stricture |
|
– | +/- | – | – | – | – | – | – | – | – | + | – | – | – | – | – | – | – | – | – | – | – | |||
Gynecological Pathology |
Pelvic inflammatory disease |
|
– | – |
|
+ | + | + | – | + | – | – | + | – |
|
– |
|
– | – | – | – |
|
– | |||
| Ovarian torsion | + | – |
|
– | + | – | – | – | – | – | – | – |
|
– | – | – | – | – | – | – | – | – | – | |||
| Ectopic pregnancy |
|
+ | – |
|
– | + | – | – | + | – | + (if ruptured) | + | – | – |
|
– | – | – | – | + | +/- | – | N/A | – | ||
Prostate Pathology |
Prostatitis |
|
– | + |
|
+ | + | – | – | – | – | – | + | – | – |
|
– | – | – | – | – | – | – | |||
| Prostatic cancer |
|
– | + | – | – | – | – | – | + | – | – | + | – | – |
|
– |
|
– | – | – | – |
|
– | |||
Testicular Pathology |
Testicular torsion |
|
+ | – |
|
– | + | – | – | +/- | – | – | +/- | – |
|
– | – | – | – | – | – | – | – | – |
|
– |
| Orchitis |
|
+ | – |
|
+ | + | – | – | – | – | – | +/- | – |
|
– | – | – | – | – | – | – | – |
|
– | ||
Abdominal Pathology |
Cholecystitis |
|
+ | – | + | + | – | – | + | – | – | – | – | – | – | – | – | – |
|
– | + | +/- |
|
– | ||
| Appendicitis |
|
+ | – |
|
+ | + | – | – | + | – | + | +/- | – | – | – |
|
– | – | – | – | – | – | + (if perforation) |
|
– | |
| Diverticulitis |
|
+ | – | + | + | – | – | + | + | – | – | – | – | – | – | – | – | – | – | + (if perforation) |
|
– | ||||
| Abdominal aortic aneurysm | – | – |
|
– | + | + | – | – | – | + (if rupture) | – | – | – | – | – | – | – | – | – | – | – | – |
|
– | ||
| Portal vein thrombosis | + | – | + | + | + | – | + | – | + (if bowel ischemia or infarction-secondary to extension of thrombus to superior mesenteric vein) | – | – | – | – | – | – | – | – | + | + (if bowel infarction, perforation) |
|
||||||
| Duodenal ulcer |
|
+ | – | + | + | + | – | – | – | + (if perforation) | – | – | – | – | – | – | – | + (if bowel perforation) | – | |||||||
| Ischemic colitis |
|
+ | – |
|
+ | + | + (if necrosis and sepsis) | + | + | + | + (if transmural necrosis) | – | – | – |
|
– | – | – | – | + (if bowel perforation) |
|
– | ||||
References
- ↑ Worcester EM, Coe FL (June 2008). “Nephrolithiasis”. Prim. Care. 35 (2): 369–91, vii. doi:10.1016/j.pop.2008.01.005. PMC 2518455. PMID 18486720.
- ↑ Semins MJ, Matlaga BR (February 2010). “Medical evaluation and management of urolithiasis”. Ther Adv Urol. 2 (1): 3–9. doi:10.1177/1756287210369121. PMC 3126068. PMID 21789078.
- ↑ Venkatesh L, Hanumegowda RK (June 2017). “Acute Pyelonephritis – Correlation of Clinical Parameter with Radiological Imaging Abnormalities”. J Clin Diagn Res. 11 (6): TC15–TC18. doi:10.7860/JCDR/2017/27247.10033. PMC 5535453. PMID 28764263.
- ↑ Garin EH, Olavarria F, Araya C, Broussain M, Barrera C, Young L (July 2007). “Diagnostic significance of clinical and laboratory findings to localize site of urinary infection”. Pediatr. Nephrol. 22 (7): 1002–6. doi:10.1007/s00467-007-0465-7. PMID 17375337.
- ↑ Lee DG, Jeon SH, Lee CH, Lee SJ, Kim JI, Chang SG (April 2009). “Acute pyelonephritis: clinical characteristics and the role of the surgical treatment”. J. Korean Med. Sci. 24 (2): 296–301. doi:10.3346/jkms.2009.24.2.296. PMC 2672131. PMID 19399273.
- ↑ Saeed K (2012). “Renal infarction”. Int J Nephrol Renovasc Dis. 5: 119–23. doi:10.2147/IJNRD.S33768. PMC 3437809. PMID 22969301.
- ↑ Mahamid M, Francis A, Abid A, Awawde M, Abu-Elhija O (2014). “Embolic renal infarction mimicking renal colic”. Int J Nephrol Renovasc Dis. 7: 157–9. doi:10.2147/IJNRD.S59745. PMC 4011809. PMID 24812524.
- ↑ Korzets Z, Plotkin E, Bernheim J, Zissin R (October 2002). “The clinical spectrum of acute renal infarction”. Isr. Med. Assoc. J. 4 (10): 781–4. PMID 12389340.
- ↑ Brix AE (2002). “Renal papillary necrosis”. Toxicol Pathol. 30 (6): 672–4. doi:10.1080/01926230290166760. PMID 12512867.
- ↑ Eknoyan G, Qunibi WY, Grissom RT, Tuma SN, Ayus JC (March 1982). “Renal papillary necrosis: an update”. Medicine (Baltimore). 61 (2): 55–73. PMID 7038374.
- ↑ Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, Sandler CM (October 2008). “Renal cell carcinoma: diagnosis, staging, and surveillance”. AJR Am J Roentgenol. 191 (4): 1220–32. doi:10.2214/AJR.07.3568. PMID 18806169.
- ↑ Ares Valdés Y, Amador Sandoval B, Morales JC, Alonso Domínguez F, Carballo Velásquez L, Fragas Valdés R, Shou Rodríguez A (September 2004). “[The role of CT scan in the diagnosis of renal cell carcinoma]”. Arch. Esp. Urol. (in Spanish; Castilian). 57 (7): 737–42. PMID 15536955.
- ↑ Leveridge MJ, Bostrom PJ, Koulouris G, Finelli A, Lawrentschuk N (June 2010). “Imaging renal cell carcinoma with ultrasonography, CT and MRI”. Nat Rev Urol. 7 (6): 311–25. doi:10.1038/nrurol.2010.63. PMID 20479778.
- ↑ Tritschler S, Roosen A, Füllhase C, Stief CG, Rübben H (March 2013). “Urethral stricture: etiology, investigation and treatments”. Dtsch Arztebl Int. 110 (13): 220–6. doi:10.3238/arztebl.2013.0220. PMC 3627163. PMID 23596502.
- ↑ Mundy AR, Andrich DE (January 2011). “Urethral strictures”. BJU Int. 107 (1): 6–26. doi:10.1111/j.1464-410X.2010.09800.x. PMID 21176068.
- ↑ Maciejewski C, Rourke K (February 2015). “Imaging of urethral stricture disease”. Transl Androl Urol. 4 (1): 2–9. doi:10.3978/j.issn.2223-4683.2015.02.03. PMC 4708283. PMID 26816803.
- ↑ Soper DE (August 2010). “Pelvic inflammatory disease”. Obstet Gynecol. 116 (2 Pt 1): 419–28. doi:10.1097/AOG.0b013e3181e92c54. PMID 20664404.
- ↑ Paavonen J (October 1998). “Pelvic inflammatory disease. From diagnosis to prevention”. Dermatol Clin. 16 (4): 747–56, xii. PMID 9891675.
- ↑ Lee MH, Moon MH, Sung CK, Woo H, Oh S (December 2014). “CT findings of acute pelvic inflammatory disease”. Abdom Imaging. 39 (6): 1350–5. doi:10.1007/s00261-014-0158-1. PMID 24802548.
- ↑ Eggert J, Sundquist K, van Vuuren C, Fianu-Jonasson A (October 2006). “The clinical diagnosis of pelvic inflammatory disease–reuse of electronic medical record data from 189 patients visiting a Swedish university hospital emergency department”. BMC Womens Health. 6: 16. doi:10.1186/1472-6874-6-16. PMC 1624808. PMID 17054801.
- ↑ Washington C, Carmichael JC (December 2012). “Management of ischemic colitis”. Clin Colon Rectal Surg. 25 (4): 228–35. doi:10.1055/s-0032-1329534. PMC 3577613. PMID 24294125.
- ↑ Chawla YK, Bodh V (March 2015). “Portal vein thrombosis”. J Clin Exp Hepatol. 5 (1): 22–40. doi:10.1016/j.jceh.2014.12.008. PMC 4415192. PMID 25941431.
- ↑ “Imaging of Abdominal Aortic Aneurysms – – American Family Physician”.
- ↑ Aggarwal S, Qamar A, Sharma V, Sharma A (2011). “Abdominal aortic aneurysm: A comprehensive review”. Exp Clin Cardiol. 16 (1): 11–5. PMC 3076160. PMID 21523201.
- ↑ Destigter KK, Keating DP (August 2009). “Imaging update: acute colonic diverticulitis”. Clin Colon Rectal Surg. 22 (3): 147–55. doi:10.1055/s-0029-1236158. PMC 2780264. PMID 20676257.
- ↑ Hameed AM, Lam VW, Pleass HC (February 2015). “Significant elevations of serum lipase not caused by pancreatitis: a systematic review”. HPB (Oxford). 17 (2): 99–112. doi:10.1111/hpb.12277. PMC 4299384. PMID 24888393.
- ↑ “Imaging for Suspected Appendicitis – – American Family Physician”.
- ↑ “CT Findings of Acute Cholecystitis and Its Complications : American Journal of Roentgenology : Vol. 194, No. 6 (AJR)”.
- ↑ “Epididymitis and Orchitis: An Overview – – American Family Physician”.
- ↑ Jia JB, Houshyar R, Verma S, Uchio E, Lall C (January 2016). “Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology”. Eur J Radiol. 85 (1): 261–267. doi:10.1016/j.ejrad.2015.10.013. PMID 26526901.
- ↑ Bratt O, Lilja H (January 2015). “Serum markers in prostate cancer detection”. Curr Opin Urol. 25 (1): 59–64. doi:10.1097/MOU.0000000000000128. PMC 4315142. PMID 25393274.
- ↑ “Prostate Cancer (Prostate Carcinoma): Symptoms – National Library of Medicine – PubMed Health”.
- ↑ Eskicioğlu F, Özdemir AT, Turan GA, Gür EB, Kasap E, Genç M (November 2014). “The efficacy of complete blood count parameters in the diagnosis of tubal ectopic pregnancy”. Ginekol. Pol. 85 (11): 823–7. PMID 25675798.
- ↑ Sivalingam VN, Duncan WC, Kirk E, Shephard LA, Horne AW (October 2011). “Diagnosis and management of ectopic pregnancy”. J Fam Plann Reprod Health Care. 37 (4): 231–40. doi:10.1136/jfprhc-2011-0073. PMC 3213855. PMID 21727242.
[[Category:Disease]
Epidemiology and Demographics
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Overview
The prevalence and demographic characteristics of renal papillary necrosis depend on the causative agent.
Epidemiology and Demographics
Prevalence
- Renal papillary necrosis due to analgesic abuse is more prevalent in Australia and England and less in the US. [1]
- In Australia, the prevalence of renal papillary necrosis ranges from 15000 per 100,000 persons to 20000 per 100,000 persons requiring kidney transplant. [1]
- The prevalence of renal papillary necrosis was reported 65,000 per 100,000 patients with sickle cell disease. [2]
- In Africa, the prevalence of symptomatic renal papillary necrosis was reported 2300 per 100,000 patients with sickle cell disease with homozygous S. [3]
Incidence
- In developing countries, the incidence of renal papillary necrosis is 3900 per 100,000 persons.[4]
- The incidence of renal papillary necrosis is 30,000 to 40,000 per 100,000 patients with Sickle cell disease. [5]
Age
- The prevalence of renal papillary necrosis increases with age. It commonly affects the elderly (>60 years). “Renal Papillary Necrosis – American Urological Association”.
- Renal papillary necrosis due to sickle cell disease commonly affects adults in the third and fourth decades.[6]
Gender
- Renal papillary necrosis is more prevalent in women.[1][3]
Race
References
- ↑ 1.0 1.1 1.2 Brix AE (2002). “Renal papillary necrosis”. Toxicol Pathol. 30 (6): 672–4. doi:10.1080/01926230290166760. PMID 12512867.
- ↑ Pandya KK, Koshy M, Brown N, Presman D (1976). “Renal papillary necrosis in sickle cell hemoglobinopathies”. J Urol. 115 (5): 497–501. doi:10.1016/s0022-5347(17)59255-1. PMID 1271537.
- ↑ 3.0 3.1 Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K (2016). “Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria”. Niger J Clin Pract. 19 (4): 471–4. doi:10.4103/1119-3077.183299. PMID 27251962.
- ↑ Dahniya MH, Szmigielski W, Reddy CK, Hanna RM, Cherian MJ, Mattar MS; et al. (1992). “Renal papillary necrosis in Kuwait”. Trop Geogr Med. 44 (4): 331–7. PMID 1295143.
- ↑ Alhwiesh A (2014). “An update on sickle cell nephropathy”. Saudi J Kidney Dis Transpl. 25 (2): 249–65. doi:10.4103/1319-2442.128495. PMID 24625990.
- ↑ Henderickx MMEL, Brits T, De Baets K, Seghers M, Maes P, Trouet D; et al. (2017). “Renal papillary necrosis in patients with sickle cell disease: How to recognize this ‘forgotten’ diagnosis”. J Pediatr Urol. 13 (3): 250–256. doi:10.1016/j.jpurol.2017.01.020. PMID 28341428.
Risk Factors
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Overview
The most potent risk factor in the development of renal papillary necrosis is analgesics abuse. Other risk factors include pyelonephritis, diabetes, renal transplant rejection, sickle cell disease, urinary tract obstruction, cirrhosis, dehydration, hypotensive shock and hypoxia.
Common Risk Factors
- The most potent risk factor in the development of renal papillary necrosis is analgesics abuse. Other risk factors include pyelonephritis, diabetes, renal transplant rejection, sickle cell disease, urinary tract obstruction, cirrhosis, dehydration, hypotensive shock and hypoxia. [1][2]
References
- ↑ “Renal papillary necrosis: MedlinePlus Medical Encyclopedia”.
- ↑ Eknoyan G, Qunibi WY, Grissom RT, Tuma SN, Ayus JC (1982). “Renal papillary necrosis: an update”. Medicine (Baltimore). 61 (2): 55–73. doi:10.1097/00005792-198203000-00001. PMID 7038374.
[[Category:Disease]
Natural History, Complications and Prognosis
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Overview
Common complications of renal papillary necrosis include Kidney infection and stones, chronic renal failure, kidney cancers, hypertension, anemia and ESRD. Prognosis depends on the underlying condition.
Natural History
- Renal papillary necrosis is associated with damage of the renal papilla due to systemic diseases and analgesics abuse. [1]
Complications
- Common complications of renal papillary necrosis include[1] “Renal Papillary Necrosis – an overview | ScienceDirect Topics”.:
Prognosis
- The prognosis of renal papillary necrosis depends on the underlying condition.
References
- ↑ 1.0 1.1 “Renal Papillary Necrosis”. Medline. NIH. Retrieved 15 October 2015.
Diagnosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | X ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
